BIOMAT Database Logo BIOMAT Database Logo

Lack of deleterious effect of slow-release sodium fluoride treatment on cortical bone histology and quality in osteoporotic patients. 1992

J E Zerwekh, and P P Antich, and K Sakhaee, and J Prior, and J Gonzales, and F Gottschalk, and C Y Pak
Center for Mineral Metabolism and Clinical Research, University of Texas Southwestern Medical Center, Dallas 72535-8885.

We evaluated the effects of intermittent slow-release sodium fluoride (SRNaF) and continuous calcium citrate therapy on cortical bone histology, reflection ultrasound velocity (material strength) and back-scattered electron image analysis (BEI) in 26 osteoporotic patients before and following therapy. All measurements were made on transiliac crest bone biopsies obtained before and following 2 years of therapy in each patient. For all 26 patients there were no significant changes in cortical bone histomorphometric parameters. In 15 patients in whom bone material quality was assessed by reflection ultrasound, there was no change in velocity (4000 +/- 227 SD to 4013 +/- 240 m/s). BEI disclosed no mineralization defects or the presence of woven bone. Mean atomic number (density) of bone increased slightly, but significantly (9.261 +/- 0.311 to 9.457 +/- 0.223, P = 0.031). While these changes are less marked than those observed for cancellous bone, they indicate that this form of therapy does not adversely affect cortical bone remodelling.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010024 Osteoporosis Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis. Age-Related Osteoporosis,Bone Loss, Age-Related,Osteoporosis, Age-Related,Osteoporosis, Post-Traumatic,Osteoporosis, Senile,Senile Osteoporosis,Osteoporosis, Involutional,Age Related Osteoporosis,Age-Related Bone Loss,Age-Related Bone Losses,Age-Related Osteoporoses,Bone Loss, Age Related,Bone Losses, Age-Related,Osteoporoses,Osteoporoses, Age-Related,Osteoporoses, Senile,Osteoporosis, Age Related,Osteoporosis, Post Traumatic,Post-Traumatic Osteoporoses,Post-Traumatic Osteoporosis,Senile Osteoporoses
D002951 Citrates Derivatives of CITRIC ACID.
D003692 Delayed-Action Preparations Dosage forms of a drug that act over a period of time by controlled-release processes or technology. Controlled Release Formulation,Controlled-Release Formulation,Controlled-Release Preparation,Delayed-Action Preparation,Depot Preparation,Depot Preparations,Extended Release Formulation,Extended Release Preparation,Prolonged-Action Preparation,Prolonged-Action Preparations,Sustained Release Formulation,Sustained-Release Preparation,Sustained-Release Preparations,Timed-Release Preparation,Timed-Release Preparations,Controlled-Release Formulations,Controlled-Release Preparations,Extended Release Formulations,Extended Release Preparations,Slow Release Formulation,Sustained Release Formulations,Controlled Release Formulations,Controlled Release Preparation,Controlled Release Preparations,Delayed Action Preparation,Delayed Action Preparations,Formulation, Controlled Release,Formulations, Controlled Release,Prolonged Action Preparation,Release Formulation, Controlled,Release Formulations, Controlled,Sustained Release Preparation,Timed Release Preparation,Timed Release Preparations
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

J E Zerwekh, and P P Antich, and K Sakhaee, and J Prior, and J Gonzales, and F Gottschalk, and C Y Pak
Effect of slow-release sodium fluoride on cancellous bone histology and connectivity in osteoporosis.
January 1994, Bone,
J E Zerwekh, and P P Antich, and K Sakhaee, and J Prior, and J Gonzales, and F Gottschalk, and C Y Pak
Effects of sodium fluoride, vitamin D, and calcium on cortical bone remodeling in osteoporotic patients.
December 1989, Calcified tissue international,
J E Zerwekh, and P P Antich, and K Sakhaee, and J Prior, and J Gonzales, and F Gottschalk, and C Y Pak
[Value of bone fluoride determination in osteoporotic patients treated with sodium fluoride].
April 1989, Presse medicale (Paris, France : 1983),
J E Zerwekh, and P P Antich, and K Sakhaee, and J Prior, and J Gonzales, and F Gottschalk, and C Y Pak
The effect of exercise on bone mass of osteoporotic patients on fluoride treatment.
March 1987, Clinical and investigative medicine. Medecine clinique et experimentale,
J E Zerwekh, and P P Antich, and K Sakhaee, and J Prior, and J Gonzales, and F Gottschalk, and C Y Pak
Deleterious effect of sodium fluoride on gastrointestinal tract.
January 1989, General pharmacology,
J E Zerwekh, and P P Antich, and K Sakhaee, and J Prior, and J Gonzales, and F Gottschalk, and C Y Pak
[Histological study of bone in osteoporotic patients receiving prolonged treatment with sodium fluoride].
October 1972, Revue du rhumatisme et des maladies osteo-articulaires,
J E Zerwekh, and P P Antich, and K Sakhaee, and J Prior, and J Gonzales, and F Gottschalk, and C Y Pak
[Bone insufficiency fractures in osteoporotic patients treated with sodium fluoride].
January 1989, Presse medicale (Paris, France : 1983),
J E Zerwekh, and P P Antich, and K Sakhaee, and J Prior, and J Gonzales, and F Gottschalk, and C Y Pak
Effect of controlled local release of sodium fluoride on trabecular bone.
July 1992, Journal of orthopaedic research : official publication of the Orthopaedic Research Society,
J E Zerwekh, and P P Antich, and K Sakhaee, and J Prior, and J Gonzales, and F Gottschalk, and C Y Pak
The effect of sodium fluoride and sodium monofluorophosphate on the mechanical properties of normal and osteoporotic rat bone.
March 1971, Israel journal of medical sciences,
J E Zerwekh, and P P Antich, and K Sakhaee, and J Prior, and J Gonzales, and F Gottschalk, and C Y Pak
Measurement of intrinsic bone quality in vivo by reflection ultrasound: correction of impaired quality with slow-release sodium fluoride and calcium citrate.
March 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research,
Copied contents to your clipboard!